Product Information
ERYTHROMYCIN DR 250 MG CAP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $5.9600 per EA under NDC 75907007601. Its NADAC has been published 88 times since Oct 23, 2024.
Strength
250 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
75907007601
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ERYTHROMYCINApproval Type
Authorized Generic (NDA)
FDA Application
NDA050536On Market Since
9/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 250 MG CAP has been published 88 times since Oct 23, 2024, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.9600 per EA |
|---|---|
| All-time high | $6.6741 (May 14, 2025) |
| All-time low | $5.9600 (Apr 22, 2026) |
| 52-week high | $6.6472 |
| 52-week low | $5.9600 |
| Median price | $6.4176 |
| Average price | $6.4251 |
| Largest weekly change | -5.4% (Apr 22, 2026) |
| Weeks tracked | 88 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the erythromycin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 250 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG CAP, manufactured by Dr. Reddy's Laboratories Inc., is $5.9600 per EA (NDC 75907007601), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN DR 250 MG CAP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG CAP has declined 10.7%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG CAP?
Since Oct 23, 2024, the NADAC for ERYTHROMYCIN DR 250 MG CAP has ranged from a low of $5.9600 (Apr 22, 2026) to a high of $6.6741 (May 14, 2025), with a median of $6.4176 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ERYTHROMYCIN DR 250 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN DR 250 MG CAP?
ERYTHROMYCIN DR 250 MG CAP (NDC 75907007601) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification